Fig. 4From: An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism a–f Mean (±SD) hormone levels from pretreatment baseline to Week 52 of the combined treatment phaseBack to article page